Meghmani Organics Ltd Hits All-Time Low Amid Continued Market Underperformance

Stock Performance Overview

On 20 Jan 2026, Meghmani Organics Ltd’s share price touched an intraday low of Rs.56.04, representing a 5.51% drop during the trading session. The stock closed with a day change of -4.91%, considerably underperforming the Sensex, which declined by 1.42% on the same day. This marks the third consecutive day of losses, with the stock shedding 8.22% over this period.

Over longer time frames, the stock’s performance has been markedly weaker than the broader market. In the past week, Meghmani Organics declined by 7.95% compared to the Sensex’s 1.87% fall. The one-month return stands at -8.53% versus the Sensex’s -3.37%, while the three-month performance shows a steep decline of 29.76%, far exceeding the Sensex’s 2.72% drop. The one-year return is particularly stark, with Meghmani Organics down 30.47%, contrasting with the Sensex’s positive 6.48% gain.

Year-to-date, the stock has lost 12.27%, again underperforming the Sensex’s 3.70% decline. The three-year and five-year returns further highlight the stock’s challenges, with losses of 46.62% and no appreciable gains respectively, while the Sensex has delivered 35.38% and 64.82% returns over the same periods. Over a decade, Meghmani Organics has not recorded any price appreciation, whereas the Sensex has surged by 241.07%.

Technical Indicators and Valuation Metrics

Meghmani Organics is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained bearish trend. The stock’s valuation metrics present a complex picture. Despite the price decline, the company’s Return on Capital Employed (ROCE) for the latest half-year period stands at 7.30%, its highest recorded level, while the Return on Equity (ROE) averages 6.03%, indicating modest profitability relative to shareholders’ funds.

The company’s net sales for the latest six months have grown by 24.34% to Rs.1,190.88 crores, and profit after tax (PAT) has increased to Rs.24.23 crores. These figures suggest operational improvements amid the broader price weakness. The stock’s enterprise value to capital employed ratio is 1, which is considered very attractive, and its PEG ratio of 0.3 reflects a low price relative to earnings growth.

Fundamental Assessment and Market Position

Despite recent positive quarterly results, Meghmani Organics’ long-term fundamentals remain under pressure. The company has experienced a negative compound annual growth rate (CAGR) of -18.02% in operating profits over the last five years, reflecting a contraction in core earnings. This trend has contributed to the stock’s downgrading in quality assessments, with its Mojo Score currently at 32.0 and a Mojo Grade of Sell, an improvement from a previous Strong Sell rating as of 1 Jan 2026.

Market capitalisation metrics also reflect challenges, with a Market Cap Grade of 3 indicating a modest size relative to peers. Notably, domestic mutual funds hold no stake in Meghmani Organics, a factor that may suggest limited institutional conviction or concerns regarding the company’s valuation or business prospects.

The stock has consistently underperformed the BSE500 benchmark over the past three years, with negative returns in each of the last three annual periods. This persistent underperformance underscores the difficulties faced by the company in delivering shareholder value relative to the broader market and sector peers.

Sector and Peer Comparison

Within the Pesticides & Agrochemicals sector, Meghmani Organics’ recent underperformance is notable. The stock has lagged its sector by 3.65% on the day of the all-time low, and its valuation remains discounted compared to historical averages of its peers. While the company’s profitability metrics such as ROCE and PAT growth show some improvement, these have not translated into positive price momentum.

The stock’s trading below all major moving averages further emphasises the prevailing negative sentiment. The lack of institutional ownership and the company’s modest returns on equity highlight the challenges in competing effectively within the sector.

Summary of Key Financial Metrics

Meghmani Organics’ recent financial disclosures reveal a mixed picture. The company has reported positive results for five consecutive quarters, with net sales for the latest six months reaching Rs.1,190.88 crores, a growth of 24.34%. Profit after tax has increased to Rs.24.23 crores, and the ROCE for the half-year period is at 7.30%, the highest in recent times.

However, the long-term trend in operating profits remains negative, with a -18.02% CAGR over five years. The average return on equity of 6.03% indicates limited profitability relative to shareholder funds. The stock’s valuation metrics, including a PEG ratio of 0.3 and an enterprise value to capital employed ratio of 1, suggest that the market is pricing in subdued expectations.

Institutional absence and consistent underperformance against benchmarks further contextualise the stock’s current valuation and price trajectory.

Conclusion

Meghmani Organics Ltd’s fall to an all-time low of Rs.56.04 marks a significant point in its price history, reflecting a prolonged period of underperformance relative to the Sensex and sector peers. While recent financial results show some improvement in sales and profitability metrics, the company’s long-term earnings growth and returns on equity remain subdued. The stock’s trading below all major moving averages and absence of domestic mutual fund holdings underline the cautious stance adopted by the market. These factors collectively illustrate the severity of the current situation for Meghmani Organics within the Pesticides & Agrochemicals sector.

Unlock special upgrade rates for a limited period. Start Saving Now →